NCT07566975 Real-World Assessment of VEVYE® for Short-Term Symptom and Sign Improvement of Dry Eye Disease in a Neuro-Ophthalmology Clinic: A 6-Month Prospective Observational Study
| NCT ID | NCT07566975 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Neuro-Ophthalmology of Texas |
| Condition | Dry Eye |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-03-31 |
| Primary Completion | 2026-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2026-03-31 with a primary completion date of 2026-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
patients from a Neuro Ophthalmology who have dry eye, some of which have neurotrophic keratitis are being analyzed after treatment with Vevye
Eligibility Criteria
Inclusion Criteria: * Age18 yr or older Diagnosis of neuro-ophthalmic condition Clinical diagnosis of dry eye disease OSDI score of 23 or greater at baseline Objective sign present Indicated for VEVYE prior to enrollment Ability and willingness to complete study visits and questionnaires Exclusion Criteria: * Patients with a corneal ulcer Use of another cyclosporine or lifitegrast product within 30 days of baseline Ocular surgery within 30 prior to baseline Active ocular infection or severe ocular surface condition unrelated to DED Contact lens wearers ( must be off contacts for 30 days and the duration of trial) Any condition that prevents compliance or informed consent Subjects with severe scarring / zero sensitivity
Contact & Investigator
Rosa A. Tang
PRINCIPAL INVESTIGATOR
Neuro Ophthalmology of TX
Frequently Asked Questions
Who can join the NCT07566975 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Dry Eye. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07566975 currently recruiting?
Yes, NCT07566975 is actively recruiting participants. Contact the research team at lperez@neuroeye.com for enrollment information.
Where is the NCT07566975 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT07566975 clinical trial?
NCT07566975 is sponsored by Neuro-Ophthalmology of Texas. The principal investigator is Rosa A. Tang at Neuro Ophthalmology of TX. The trial plans to enroll 50 participants.